BACKGROUND AND OBJECTIVE: Cell therapy can be considered as a strategy aimed at
replacing, repairing, or enhancing the biological function of a damaged tissue or system by …

Dendritic cells (DC) are potent antigen presenting cells that are essential for the initiation of
primary immune responses. They richly express MHC, costimulatory and adhesion …

Dendritic cells (DC), the most potent'professional'antigen-presenting cells, hold promise for
improving the immunotherapy of cancer. In this study, we investigated the ability of normal …

Adoptive immunotherapy in form of donor leukocyte infusions is effective in a significant
number of patients with chronic myeloid leukemia (CML) that have relapsed after allogeneic …

Peptides corresponding to the fusion site in 210 kD BCR-ABL protein b3a2 (p210b3a2)
were previously shown to bind to several HLA class I and II alleles. We have found that b3a2 …

The confirmation that most cancers express one or more molecular changes, which may act
as tumour‐associated antigens (TAA), combined with the knowledge that T lymphocytes …

Advances in understanding the role of dendritic cells (DCs) as the major antigen (Ag)-
presenting cell type of the immune system combined with the recent development of …

Effective host T lymphocyte sensitization to malignant cells depends on successful antigen
presentation. In this study, we examined the capacity of malignant myeloid progenitor cells …

At this workshop, clinicians active in the use of dendritic cells all expressed the need to have
an available supply of interleukin (IL)‐4. There was discussion that unless some institution …

The goal of harnessing the immune system to recognize tumor as" nonself" is not new. Now,
thanks to new knowledge and new techniques, however, modalities that seek to activate the …